MOATAZEDI DAVID — Insider transactions, Director at Evolus, Inc. / OBALON THERAPEUTICS INC | InsiderLens

FrançaisSign in Try free 14d

MOATAZEDI DAVID

USNatural personDirector2 companies · 24mo

Transactions

67

Issuers

3

Buys / Sells

0/28

Last tx

20 Mar 2026

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

Issuer	Shares	Source	Last tx	Detail
Evolus, Inc.	604,700	reported	20 Mar 2026	tx 58+6,340,488−1,789,109
OBALON THERAPEUTICS INC	83,619	reported	23 Jul 2019	tx 6+338,215−5,494
BIOMERICA INC	30,625	reported	12 Dec 2025	tx 5+237,000

Recent transactions

Date	Type	Issuer	Qty	Price	Signals
20 Mar 2026	SALE	Evolus, Inc.	13,669	4.75 USD
17 Mar 2026	SALE	Evolus, Inc.	116,720	4.89 USD
16 Mar 2026	EXERCISE	Evolus, Inc.	67,489	0.00 USD
16 Mar 2026	EXERCISE	Evolus, Inc.	67,489	0.00 USD	deriv
17 Feb 2026	GRANT_AWARD	Evolus, Inc.	313,212	0.00 USD
17 Feb 2026	GRANT_AWARD	Evolus, Inc.	626,424	0.00 USD	deriv
17 Feb 2026	GRANT_AWARD	Evolus, Inc.	457,541	0.00 USD	deriv
12 Dec 2025	GRANT_AWARD	BIOMERICA INC	20,000	0.00 USD
22 Dec 2025	SALE	Evolus, Inc.	10,539	7.15 USD
16 Jun 2025	SALE	Evolus, Inc.	16,582	9.89 USD
13 Jun 2025	SALE	Evolus, Inc.	111,323	10.05 USD
12 May 2025	SALE	Evolus, Inc.	15,787	9.87 USD
27 Mar 2025	SALE	Evolus, Inc.	6,251	12.40 USD
18 Mar 2025	SALE	Evolus, Inc.	103,376	13.26 USD
07 Mar 2025	GRANT_AWARD	Evolus, Inc.	95,399	0.00 USD
07 Mar 2025	GRANT_AWARD	Evolus, Inc.	135,925	0.00 USD	deriv
07 Mar 2025	GRANT_AWARD	Evolus, Inc.	190,799	0.00 USD	deriv
23 Dec 2024	SALE	Evolus, Inc.	10,502	10.85 USD
13 Dec 2024	GRANT_AWARD	BIOMERICA INC	85,000	0.31 USD
05 Jun 2024	SALE	Evolus, Inc.	155,278	12.92 USD
06 Jun 2024	EXERCISE	Evolus, Inc.	175,940	7.28 USD
06 Jun 2024	SALE	Evolus, Inc.	175,940	12.59 USD
04 Jun 2024	SALE	Evolus, Inc.	140,214	12.73 USD
05 Jun 2024	EXERCISE	Evolus, Inc.	155,278	5.46 USD
05 Jun 2024	EXERCISE	Evolus, Inc.	155,278	0.00 USD	deriv